September 30 in Boston: Special event with Whitehead Founding Member Rudolf Jaenisch

Rudolf Jaenisch

Please join us for an exciting opportunity on Wednesday, September 30 at 6:00 pm at the Pucker Gallery. Dr. Rudolf Jaenisch will present “The Power and Promise of Stem Cells for Understanding and Treating Diabetes.”


About the speaker
Dr. Rudolf Jaenisch is a founding faculty member of Whitehead Institute and one of the world’s leading researchers in stem cell biology. He is a pioneer in the study of cellular reprogramming, the process of converting adult cells to induced pluripotent stem (iPS) cells. Dr. Jaenisch’s lab was the fi­rst to create a transgenic animal model, as well as the fi­rst to conduct an experiment showing that therapeutic cloning could correct genetic defects in mice. In 2007, the Jaenisch lab was one of three labs worldwide that reported successfully reprogramming mouse skin cells into iPS cells. He has since shown therapeutic benefi­ts of iPS cell-based treatment for sickle-cell anemia and Parkinson’s disease. Dr. Jaenisch is currently using patient-derived iPS cells to develop sophisticated models for the study of diabetes, cardiovascular disease, and neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease.

Dr. Jaenisch received his doctorate in medicine from the University of Munich in 1967. Before coming to Whitehead, he was head of the Department of Tumor Virology at the Heinrich Pette Institute at the University of Hamburg. Over the course of his distinguished career, Dr. Jaenisch has co-authored nearly 400 research papers and has received a number of prestigious honors, including the Wolf Prize in Medicine in 2011, the National Medal of Science in 2011, the Otto Warburg Medal in 2014, and the March of Dimes Prize in Developmental Biology in 2015.